Clinical Trial Update: Paclitaxel and Cisplatin for Thymic Neoplasm [Phase 2]

View source ↗

Summary

Phase 2 trial of Paclitaxel and Cisplatin for thymic neoplasms (thymoma and thymic carcinoma) has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thymic Carcinoma
• Thymoma

Drugs mentioned

• CISPLATIN (cisplatin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Korean Cancer Study Group | Conditions: Thymoma, Thymic Carcinoma | Phase 2 | Status: TERMINATED